Related Experiment Video
Updated: Jan 16, 2026

09:40
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
3.2K
RecOVARY? Using anti-Müllerian hormone to predict ovarian function after anti-HER2 therapy for early breast cancer
Lynn K Symonds1,2, Nancy E Davidson1,2
1Fred Hutchinson Cancer Center, Seattle, WA, United States.
Journal of the National Cancer Institute
|September 26, 2025
Abstract
No abstract available in PubMed .

